• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Progenics Pharmaceuticals, Inc. (PGNX)

    5.31 Down 0.19(3.45%) Apr 29, 4:00PM EDT
    |After Hours : 5.31 0.00 (0.00%) Apr 29, 4:55PM EDT
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.3
    Mean Recommendation (last week):1.3

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:10.75
    Median Target:10.00
    High Target:14.00
    Low Target:9.00
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 23, 2015JefferiesUpgradeHoldBuy
    Feb 3, 2014NeedhamUpgradeHoldBuy
    Aug 30, 2012Stifel NicolausInitiated Hold
    Jul 30, 2012NeedhamDowngradeBuyHold
    Feb 10, 2011Brean MurrayUpgradeHoldBuy
    Mar 16, 2009OppenheimerDowngradeOutperformPerform
    Mar 16, 2009Brean MurrayDowngradeBuyHold
    Mar 12, 2009FTN Equity CapitalInitiated Neutral
    Jul 2, 2008Friedman BillingsDowngradeMkt PerformUnderperform
    Apr 25, 2008CitigroupUpgradeSellHold

    More Upgrades & Downgrades for PGNX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3333

    Data provided by Thomson/First Call

    Currency in USD.